Park Avenue Securities LLC Takes Position in Bath & Body Works, Inc. (NYSE:BBWI)

Park Avenue Securities LLC bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 6,972 shares of the company's stock, valued at approximately $270,000.

Other hedge funds have also recently added to or reduced their stakes in the company. True Wealth Design LLC increased its holdings in shares of Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after purchasing an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after buying an additional 900 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in shares of Bath & Body Works during the 3rd quarter worth about $39,000. TD Private Client Wealth LLC lifted its stake in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after acquiring an additional 331 shares during the period. Finally, Meeder Asset Management Inc. boosted its stake in Bath & Body Works by 480.3% during the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company's stock valued at $55,000 after purchasing an additional 1,436 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 0.8 %

BBWI stock traded down $0.31 during midday trading on Friday, reaching $36.98. The company had a trading volume of 2,087,776 shares, compared to its average volume of 2,641,961. The company has a 50 day moving average of $36.86 and a two-hundred day moving average of $33.64. The company has a market capitalization of $8.01 billion, a P/E ratio of 9.02, a PEG ratio of 1.01 and a beta of 1.82. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the company earned $0.48 earnings per share. Bath & Body Works's quarterly revenue was up 3.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 19.51%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Telsey Advisory Group reiterated an "outperform" rating and issued a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. TD Cowen boosted their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. JPMorgan Chase & Co. raised their target price on shares of Bath & Body Works from $39.00 to $41.00 and gave the stock a "neutral" rating in a report on Friday. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, Morgan Stanley reduced their price objective on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a research note on Thursday, November 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.